Skip to main content

Advertisement

Log in

A bifunctional organometallic ruthenium drug with multiple modes of inducing apoptosis

  • Original Paper
  • Published:
JBIC Journal of Biological Inorganic Chemistry Aims and scope Submit manuscript

Abstract

The organometallic glutathione S-transferase inhibitor ruthenium(II) (ethacrynic acid-η6-benzylamide)(1,3,5-triaza-7-phosphaadamantane) dichloride, termed ethaRAPTA, has been demonstrated to induce apoptosis in the cisplatin-resistant MCF-7 breast cancer cell line. Probing the molecular basis of this activity suggests that the complex triggers multiple pathways toward apoptosis, including those involving endonuclease G, caspases, and c-Jun N-terminal kinase, which could provide a therapy for multi-drug-resistant tumors. Furthermore, the induction of heat shock protein 70 expression enhances selectivity of the complex for tumor cells, reducing the general toxicity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9

Similar content being viewed by others

References

  1. Rosenberg B, VanCamp L, Trosko JE, Mansour VH (1969) Nature 222:385–386

    Article  PubMed  CAS  Google Scholar 

  2. Kelland L (2007) Nat Rev Cancer 7:573–584

    Article  PubMed  CAS  Google Scholar 

  3. Rabik CA, Dolan ME (2007) Cancer Treat Rev 33:9–23

    Article  PubMed  CAS  Google Scholar 

  4. Strohfeldt K, Tacke M (2008) Chem Soc Rev 37:1174–1187

    Article  PubMed  CAS  Google Scholar 

  5. Rudnev AV, Foteeva LS, Kowol C, Berger R, Jakupec MA, Arion VB, Timerbaev AR, Keppler BK (2006) J Inorg Biochem 100:1819–1826

    Article  PubMed  CAS  Google Scholar 

  6. Sava G, Zorzet V, Turrin C, Vita F, Soranzo MR, Zabucchi G, Cocchietto M, Bergamo A, DiGiovine S, Pezzoni G, Sartor L, Garbisa S (2003) Clin Cancer Res 9:1898–1905

    PubMed  CAS  Google Scholar 

  7. Hartinger CG, Zorbas-Seifried S, Jakupec MA, Kynast B, Zorbas H, Keppler BK (2006) J Inorg Biochem 100:891–904

    Article  PubMed  CAS  Google Scholar 

  8. Hartinger CG, Jakupec MA, Zorbas-Seifried S, Groessl M, Egger A, Berger W, Zorbas H, Dyson PJ, Keppler BK (2008) Chem Biodivers 5(10):2140–2155

    Article  PubMed  CAS  Google Scholar 

  9. Jänicke RU (2008) Breast Cancer Res Treat 117:219–221

    Article  PubMed  Google Scholar 

  10. Porter AG, Jänicke RU (1999) Cell Death Differ 6:99–104

    Article  PubMed  CAS  Google Scholar 

  11. Hanson CJ, Bootman MD, Roderick HL (2004) Curr Biol 14:R933–R935

    Article  PubMed  CAS  Google Scholar 

  12. Dyson PJ, Sava G (2006) Dalton Trans (16):1929–1933

  13. Rademaker-Lakhai JM, van den Bongard D, Pluim D, Beijnen JH, Schellens JH (2004) Clin Cancer Res 10:3717–3727

    Article  PubMed  CAS  Google Scholar 

  14. Schluga P, Hartinger CG, Egger A, Reisner E, Galanski M, Jakupec MA, Keppler BK (2006) Dalton Trans (14):1796–1802

  15. Jakupec MA, Reisner E, Eichinger A, Pongratz M, Arion VB, Galanski M, Hartinger CG, Keppler BK (2005) J Med Chem 48:2831–2837

    Article  PubMed  CAS  Google Scholar 

  16. Clarke MJ (2003) Coord Chem Rev 236:209–232

    Article  CAS  Google Scholar 

  17. Sulyok M, Hann S, Hartinger CG, Keppler BK, Stingeder G, Koellensperger G (2005) J Anal At Spectrom 20:856–863

    Article  CAS  Google Scholar 

  18. Ang WH, Dyson PJ (2006) Eur J Inorg Chem 20:4003–4018

    Article  Google Scholar 

  19. Timerbaev AR, Hartinger CG, Aleksenko SS, Keppler BK (2006) Chem Rev 106:2224–2248

    Article  PubMed  CAS  Google Scholar 

  20. Hartinger CG, Zorbas-Seifried S, Jakupec MA, Kynast B, Zorbas H, Keppler BK (2006) J Inorg Biochem 100:891–904

    Article  PubMed  CAS  Google Scholar 

  21. Rademaker-Lakhai Jm, van den Bongard D, Pluim D, Beijnen JH, Schellens JH (2004) Clin Cancer Res 10:3717–3727

    Article  PubMed  CAS  Google Scholar 

  22. Dyson PJ (2007) Chimia 61:698–703

    Article  CAS  Google Scholar 

  23. Dyson PJ, Hartinger CG (2009) Chem Soc Rev 38:391–401

    Article  PubMed  Google Scholar 

  24. Süss-Fink G (2010) Dalton Trans 39:1673–1688

    Article  PubMed  Google Scholar 

  25. Scolaro C, Bergamo A, Brescacin L, Delfino R, Cocchietto M, Laurenczy G, Geldbach TJ, Sava G, Dyson PJ (2005) J Med Chem 48:4161–4171

    Article  PubMed  CAS  Google Scholar 

  26. Bergamo A, Masi A, Dyson PJ, Sava G (2008) Int J Oncol 33:1281–1289

    PubMed  CAS  Google Scholar 

  27. Chatterjee S, Kundu S, Bhattacharyya A, Hartinger CG, Dyson PJ (2008) J Biol Inorg Chem 13:1149–1155

    Article  PubMed  CAS  Google Scholar 

  28. Ang WH, de Luca A, Chapuis-Bernasconi C, Juillerat-Jeanneret L, Lo Bello M, Dyson PJ (2007) Chem Med Chem 2:1799–1806

    PubMed  CAS  Google Scholar 

  29. Ang WH, Parker LJ, de Luca A, Juillerat-Jeanneret L, Morton CJ, Lo Bello M, Parker MW, Dyson PJ (2009) Angew Chem Int Ed 48:3854–3857

    Article  CAS  Google Scholar 

  30. Fuertes MA, Perez JM, Alonso C (2003) Chem Rev 103:645–662

    Article  PubMed  CAS  Google Scholar 

  31. Niitsu Y, Takahashi Y, Ban N, Takayama T, Saito T, Katahira T, Umetsu Y, Nakajima T, Ohi M, Kuga T, Sakamaki S, Matsunaga T, Hirayama Y, Kuroda H, Homma H, Kato J, Kogawa K (1998) Chem Biol Interact 112:325–332

    Article  Google Scholar 

  32. Goto S, Iida T, Cho S, Oka M, Kohno S, Kondo T (1999) Free Radic Res 31:549–558

    Article  PubMed  CAS  Google Scholar 

  33. Oude Elferink RP, Bakker CT, Jansen PL (1999) Toxicol Appl Pharmacol 157:85–93

    Article  Google Scholar 

  34. Wang T, Arifoglu P, Ronai Z, Tew KD (2001) J Biol Chem 276:20999–21003

    Article  PubMed  CAS  Google Scholar 

  35. Adler V, Yin Z, Fuchs SY, Benezra M, Rosario L, Tew KD, Pincus MR, Sardana M, Henderson CJ, Wolf CR, Davis RJ, Ronai Z (1999) EMBO J 18:1321–1334

    Article  PubMed  CAS  Google Scholar 

  36. Huang J, Tan PH, Tan KH, Bay BH (2004) Oncol Rep 12:921–925

    PubMed  CAS  Google Scholar 

  37. Ang WH (2007) Novel strategies for overcoming drug resistance in transition metal-based anticancer compounds. PhD thesis, EPFL

  38. Sheehan D, Meade G (2000) Biochem Soc Trans 28:27–32

    PubMed  CAS  Google Scholar 

  39. Armstrong JS, Steinauer KK, Hornung B, Irish JM, Lecane P, Birrell GW, Peehl DM, Knox SJ (2002) Cell Death Diff 9:252–263

    Article  CAS  Google Scholar 

  40. Allardyce CS, Dyson PJ, Ellis DJ, Heath SL (2001) Chem Commun 1396–1397

  41. Gaiddon C, Jeannequin P, Bischoff P, Pfeffer M, Sirlin C, Loeffler JP (2005) J Pharmacol Exp Ther 315:1403–1411

    Article  PubMed  CAS  Google Scholar 

  42. van Rijt SH, Sadler PJ (2009) Drug Discov Today 14:1089–1097

    Article  PubMed  Google Scholar 

  43. Schmid WF, John RO, Muehlgassner G, Heffeter P, Jakupec MA, Galanski M, Berger W, Arion VB, Keppler BK (2007) J Med Chem 50:6343–6355

    Article  PubMed  CAS  Google Scholar 

  44. Debreczeni JE, Bullock AN, Atilla GE, Williams DS, Bregman H, S. Knapp S, Meggers E (2006) Angew Chem 45:1580–1585

  45. Mattsson J, Govindaswamy P, Renfrew AK, Dyson PJ, Štěpnička P, Süss-Fink G, Therrien B (2009) Organometallics 28:4350–4357

    Article  CAS  Google Scholar 

  46. Kandioller W, Hartinger CG, Nazarov AA, Kuznetsov ML, John RO, Bartel C, Jakupec MA, Arion VB, Keppler BK (2009) Organometallics 28:4249–4251

    Article  CAS  Google Scholar 

  47. Adler V, Yin Z, Fuchs SY, Benezra M, Rosario L, Tew KD, Pincus MR, Sardana M, Henderson CJ, Wolf CR, Davis RJ, Ronai Z (1999) EMBO J 18:1321–1334

    Article  PubMed  CAS  Google Scholar 

  48. Wang R, Li C, Song D, Zhao G, Zhao L, Jing Y (2007) Cancer Res 67:7856–7864

    Article  PubMed  CAS  Google Scholar 

  49. Hayes JD, Pulford DJ (1995) Crit Rev Biochem Mol Biol 30:445–600

    Article  PubMed  CAS  Google Scholar 

  50. Bernardini S, Bernassola F, Cortese C, Ballerini S, Melino G, Motti C, Bellincampi L, Iori R, Federici G (2000) J Cell Biochem 77:645–653

    Article  PubMed  CAS  Google Scholar 

  51. Braun RJ, Zischka H, Madeo F, Eisenberg T, Wissing S, Büttner S, Engelhardt SM, Büringer D, Ueffing M (2006) J Biol Chem 281:25757–25767

    Article  PubMed  CAS  Google Scholar 

  52. Dupont-Versteegden EE, Strotman BA, Gurley CM, Gaddy D, Knox M, Fluckey JD, Peterson CA (2006) Am J Physiol Regul Integr Comp Physiol 291:R1730–R1740

    Article  PubMed  CAS  Google Scholar 

  53. Delimitreva SM, Zhivkova RS, Vatev IT, Toncheva DI (2005) Int J Dev Biol 49:409–416

    Article  PubMed  Google Scholar 

  54. Kuwahara D, Tsutsumi K, Kobayashi T, Hasunuma T, Nishioka K (2000) Cancer Lett 148:65–71

    Article  PubMed  CAS  Google Scholar 

  55. Demidenko ZN, Vivo C, Halicka HD, Li CJ, Bhalla K, Broude EV, Blagosklonny MV (2006) Cell Death Differ 13:1434–1441

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The authors express their sincere gratitude to the Department of Science and Technology, India. The Indo Swiss Bilateral Research Initiative (EPFL) is also gratefully acknowledged for funding this research.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Arindam Bhattacharyya.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chatterjee, S., Biondi, I., Dyson, P.J. et al. A bifunctional organometallic ruthenium drug with multiple modes of inducing apoptosis. J Biol Inorg Chem 16, 715–724 (2011). https://doi.org/10.1007/s00775-011-0772-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00775-011-0772-0

Keywords

Navigation